Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y 1 receptors in HEK293 cells

British Journal of Pharmacology

Volumn 139, Issue 4, 2003, Pages 695-704

  Pheng, Leng Hong ^a   Dumont, Yvan ^a   Fournier, Alain ^b   Chabot, Jean Guy ^a   Beaudet, Alain ^c   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antagonist receptor internalization; Fluorescent probe; GR231118; Neuropeptide YY 1 receptor

Indexed keywords

CELL SURFACE RECEPTOR; FLUORESCENT DYE; GR 231118; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MONENSIN; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; PEPTIDE YY; PEPTIDE YY [31 LEUCINE 34 PROLINE]; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ARTICLE; CELL SURFACE; COATED VESICLE; CONCENTRATION RESPONSE; EMBRYO CELL; ENDOCYTOSIS; ENDOSOME; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTERNALIZATION; ISOTOPE LABELING; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CLATHRIN; CLATHRIN-COATED VESICLES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; IODINE RADIOISOTOPES; KIDNEY; PEPTIDE YY; PEPTIDES, CYCLIC; RADIOISOTOPES; RATS; RECEPTORS, NEUROPEPTIDE Y; TIME FACTORS; TRANSFECTION;

EID: 0037664644     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705306     Document Type: Article

References (44)

1. ADRIAN, T.E., ALLEN, J.M., BLOOM, S.R., GHATEI, M.A., ROSSOR, M.N., ROBERTS, G.W., CROW, T.J., TATEMOTO, K. & POLAK, J.M. (1983). Neuropeptide Y distribution in human brain. Nature, 306, 584-586.
2. BOHM, S.K., GRADY, E.F. & BUNNETT, N.W. (1997). Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J., 322 (Part 1), 1-18.
3. BURKHOFF, A., LINEMEYER, D.L. & SALON, J.A. (1998). Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat. Brain Res. Mol. Brain Res., 53, 311-316.
4. CHUN, M., LIYANAGE, U.K., LISANTI, M.P. & LODISH, H.F. (1994). Signal transduction of a G protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc. Natl. Acad. Sci. U.S.A., 91, 11728-11732.
5. DELANEY, K.A., MURPH, M.M., BROWN, L.M. & RADHAKRISHNA, H. (2002). Transfer of M2 muscarinic acetylcholine receptors to clathrin-derived early endosomes following clathrin-independent endocytosis. J. Biol. Chem., 277, 33439-33446.
6. DOODS, H.N., WIELAND, H.A., ENGEL, W., EBERLEIN, W., WILLIM, K.D., ENTZEROTH, M., WIENEN, W. & RUDOLF, K. (1996). BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul. Pept., 65, 71-77.
7. DUMONT, Y., FOURNIER, A., ST-PIERRE, S. & QUIRION, R. (1995). Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands. J. Pharmacol. Exp. Ther., 272, 673-680.
8. DUMONT, Y., MARTEL, J.C., FOURNIER, A., ST-PIERRE, S. & QUIRION, R. (1992). Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog. Neurobiol., 38, 125-167.
9. DUMONT, Y. & QUIRION, R. (2000). [125I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y1 and Y4 receptors. Br. J. Pharmacol., 129, 37-46.
10. DUMONT, Y., ST-PIERRE, J.A., THAKUR, M., PHENG, L.H., LANGLOIS, D., SLON-USAKIEWICZ, J., WENHAM, D., GAUDREAU, P. & QUIRION, R. (2001). Characterisation of Bodipy-conjugated fluo-neuropeptide Y analogs in Y1, Y2, Y4 and Y5 receptor binding assays. Society for Neuroscience, Abstract Viewer/Itinarary Planner. Washington, DC., Program No. 30.15.
11. DUPREE, P., PARTON, R.G., RAPOSO, G., KURZCHALIA, T.V. & SIMONS, K. (1993). Caveolae and sorting in the trans-Golgi network of epithelial cells. EMBO J., 12, 1597-1605.
12. EVA, C., KEINANEN, K., MONYER, H., SEEBURG, P. & SPRENGEL, R. (1990). Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett., 271, 81-84.
13. FABRY, M., LANGER, M., ROTHEN-RUTISHAUSER, B., WUNDERLIALLENSPACH, H., HOCKER, H. & BECK-SICKINGER, A.G. (2000). Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur. J. Biochem., 267, 5631-5637.
14. GERALD, C., WALKER, M.W., CRISCIONE, L., GUSTAFSON, E.L., BATZL-HARTMANN, C., SMITH, K.E., VAYSSE, P., DURKIN, M.M., LAZ, T.M., LINEMEYER, D.L., SCHAFFHAUSER, A.O., WHITEBREAD, S., HOFBAUER, K.G., TABER, R.I., BRANCHEK, T.A. & WEINSHANK, R.L. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168-171.
15. GICQUIAUX, H., LECAT, S., GAIRE, M., DIETERLEN, A., MELY, Y., TAKEDA, K., BUCHER, B. & GALZI, J.L. (2002). Rapid internalization and recycling of the human neuropeptide Y Y(1) receptor. J. Biol. Chem., 277, 6645-6655.
16. GRAY, J.A. & ROTH, B.L. (2001). Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists. Brain Res. Bull., 56, 441-451.
17. HAUSDORFF, W.P., CARON, M.G. & LEFKOWITZ, R.J. (1990). Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J., 4, 2881-2889.
18. HEGDE, S.S., BONHAUS, D.W., STANLEY, W., EGLEN, R.M., MOY, T.M., LOEB, M., SHETTY, S.G., DESOUZA, A. & KRSTENANSKY, J. (1995). Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist. J. Pharmacol. Exp. Ther., 275, 1261-1266.
19. HEILIG, M., SODERPALM, B., ENGEL, J.A. & WIDERLOV, E. (1989). Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacology (Berl), 98, 524-529.
20. HOULE, S., LARRIV INVERTED QUESTION MARKEE, J.F., BACHVAROVA, M., BOUTHILLIER, J., BACHVAROV, D.R. & MARCEAU, F. (2000). Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor. Hypertension, 35, 1319-1325.
21. HUNYADY, L. (1999). Molecular mechanisms of angiotensin II receptor internalization. J. Am. Soc. Nephrol., 10 (Suppl 11), S47-S56.
22. 2+ in heart and vascular smooth muscle cells. Can. J. Physiol. Pharmacol., 78, 162-172.
23. LEE, M.C., CAHILL, C.M., VINCENT, J.P. & BEAUDET, A. (2002). Internalization and trafficking of opioid receptor ligands in rat cortical neurons. Synapse, 43, 102-111.
24. LEW, M.J., MURPHY, R. & ANGUS, J.A. (1996). Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors. Br. J. Pharmacol., 117, 1768-1772.
25. MICHEL, M.C., BECK-SICKINGER, A., COX, H., DOODS, H.N., HERZOG, H., LARHAMMAR, D., QUIRION, R., SCHWARTZ, T. & WESTFALL, T. (1998). XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev., 50, 143-150.
26. NOUEL, D., GAUDRIAULT, G., HOULE, M., REISINE, T., VINCENT, J.P., MAZELLA, J. & BEAUDET, A. (1997). Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology, 138, 296-306.
27. PARKER, E.M., BABIJ, C.K., BALASUBRAMANIAM, A., BURRIER, R.E., GUZZI, M., HAMUD, F., MUKHOPADHYAY, G., RUDINSKI, M.S., TAO, Z., TICE, M., XIA, L., MULLINS, D.E. & SALISBURY, B.G. (1998). GR231118 (1229U91) and other analogues of the C-terminus of neuropeptide Y are potent neuropeptide Y Y1 receptor antagonists and neuropeptide Y Y4 receptor agonists. Eur. J. Pharmacol., 349, 97-105.
28. PARKER, S.L., KANE, J.K., PARKER, M.S., BERGLUND, M.M., LUNDELL, I.A. & LI, M.D. (2001). Cloned neuropeptide Y (NPY) Y1 and pancreatic polypeptide Y4 receptors expressed in Chinese hamster ovary cells show considerable agonist-driven internalization, in contrast to the NPY Y2 receptor. Eur. J. Biochem., 268, 877-886.
29. PARKER, S.L., PARKER, M.S., LUNDELL, I., BALASUBRAMANIAM, A., BUSCHAUER, A., KANE, J.K., YALCIN, A. & BERGLUND, M.M. (2002). Agonist internalization by cloned Y1 neuropeptide Y (NPY) receptor in Chinese hamster ovary cells shows strong preference for NPY, endosome-linked entry and fast receptor recycling. Regul. Pept., 107, 49-62.
30. PFEIFFER, R., KIRSCH, J. & FAHRENHOLZ, F. (1998). Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp. Cell Res., 244, 327-339.
31. PHENG, L.H., DUMONT, Y., FOURNIER, A., BEAUDET, A. & QUIORION, R. (2001). Regulation of cell surface neuropeptide Y Y1 receptor in HEK293 cell by agonist and antagonist. Society for Neuroscience. Abstract Viewer/Itinarary Planner. Washington, DC., Program No. 461.9.
32. PHENG, L.H. & REGOLI, D. (1998). Bioassays for NPY receptors: old and new. Regul. Pept., 75-76, 79-87.
33. ROETTGER, B.F., GHANEKAR, D., RAO, R., TOLEDO, C., YINGLING, J., PINON, D. & MILLER, L.J. (1997). Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol. Pharmacol., 51, 357-362.
34. ROETTGER, B.F., RENTSCH, R.U., PINON, D., HOLICKY, E., HADAC, E., LARKIN, J.M. & MILLER, L.J. (1995). Dual pathways of internalization of the cholecystokinin receptor. J. Cell Biol., 128, 1029-1041.
35. RUDOLF, K., EBERLEIN, W., ENGEL, W., WIELAND, H.A., WILLIM, K.D., ENTZEROTH, M., WIENEN, W., BECK-SICKINGER, A. & DOODS, H.N. (1997). BIBP3226, a potent and selective neuropeptide Y Y1-receptor antagonist. Structure-activity studies and localization of the human Y1 receptor binding site. In: Neuropeptide Y and Drug Development. ed. Grundemar, L. & Bloom, S.R., pp. 175-190. London: Academic Press.
36. SCHOBER, D.A., GACKENHEIMER, S.L., HEIMAN, M.L. & GEHLERT, D.R. (2000). Pharmacological characterization of 125I-1229U91 binding to Y1 and Y4 neuropeptide Y/peptide YY receptors. J. Pharmacol. Exp. Ther., 293, 275-280.
37. SERONE, A.P., WRIGHT, C.E. & ANGUS, J.A. (2000). Role of NPY Y1 receptors in cardiovascular control in the conscious rabbit. J. Cardiovasc. Pharmacol., 35, 315-321.
38. STANLEY, B.G. & LEIBOWITZ, S.F. (1984). Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci., 35, 2635-2642.
39. ST-PIERRE, J.A., NOUEL, D., DUMONT, Y., BEAUDET, A. & QUIRION, R. (2000). Sub-population of cultured hippocampal astrocytes expresses neuropeptide Y Y1 receptors. Glia, 30, 82-91.
40. THORSELL, A. & HEILIG, M. (2002). Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides, 36, 182-193.
41. TONG, Y., DUMONT, Y., SHEN, S.H., HERZOG, H., SHINE, J. & QUIRION, R. (1995). Expression of the neuropeptide Y Y1 receptor in human embryonic kidney 293 cells: ligand binding characteristics, in situ hybridization and receptor autoradiography. Brain Res. Mol. Brain Res., 34, 303-308.
42. TUOR, U.I., EDVINSSON, L. & MCCULLOCH, J. (1985). Neuropeptide Y and cerebral blood flow. Lancet, 1, 1271.
43. VANDENBULCKE, F., NOUEL, D., VINCENT, J.P., MAZELLA, J. & BEAUDET, A. (2000). Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J. Cell Sci., 113 (Part 17), 2963-2975.
44. VEZZANI, A., SPERK, G. & COLMERS, W.F. (1999). Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends Neurosci., 22, 25-30.